Cancer Stem Cells in Multiple Myeloma
NCT01820546 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 96
Last updated 2016-01-06
Summary
In multiple myeloma "cancer stem" cells can be defined and quantified with flow cytometry. More, these cells can be related to treatment response.
Conditions
Sponsors & Collaborators
-
Ankara University
lead OTHER
Principal Investigators
-
Mehmet Ozen, MD
Eligibility
- Min Age
- 18 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2013-01-31
- Primary Completion
- 2016-01-31
- Completion
- 2016-01-31
Countries
- Turkey (Türkiye)
Study Locations
More Related Trials
-
Chemotherapy, Vaccine Therapy, and Stem Cell Transplantation in Patients With Newly Diagnosed Multiple Myeloma
NCT00024466 ·Status: COMPLETED ·Phase: PHASE1/PHASE2
-
Temsirolimus and Cixutumumab in Treating Patients With Locally Advanced, Metastatic, or Recurrent Soft Tissue Sarcoma or Bone Sarcoma
NCT01016015 ·Status: COMPLETED ·Phase: PHASE2
-
Chemotherapy and Peripheral Stem Cell Transplantation Followed By Immunotherapy in Treating Patients With Multiple Myeloma
NCT00046852 ·Status: COMPLETED ·Phase: PHASE1/PHASE2
-
Peripheral Stem Cell Transplant in Treating Patients With Multiple Myeloma
NCT00028600 ·Status: COMPLETED ·Phase: PHASE2
-
Ex-Vivo Depletion of Myeloma Cells From Peripheral Blood Progenitor Cell Grafts
NCT00968396 ·Status: WITHDRAWN ·Phase: PHASE2
-
Melphalan and Filgrastim to Stimulate Peripheral Stem Cells in Patients With Multiple Myeloma
NCT00008268 ·Status: COMPLETED ·Phase: PHASE2
-
Combination Chemotherapy, Total Body Irradiation, and Donor Blood Stem Cell Transplant in Treating Patients With Secondary Myelofibrosis
NCT03118492 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE1
-
Study of High-Dose Chemotherapy With Bone Marrow or Stem Cell Transplant for Rare Poor-Prognosis Cancers
NCT00141765 ·Status: COMPLETED ·Phase: PHASE2
-
Combination Chemotherapy and Peripheral Stem Cell Transplantation in Treating Patients With Multiple Myeloma
NCT00004903 ·Status: UNKNOWN ·Phase: PHASE2
-
T Cells Expressing a Novel Fully-Human Anti-BCMA CAR for Treating Multiple Myeloma
NCT03602612 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE1
-
UCMSC-Exo for Chemotherapy-induced Myelosuppression in Acute Myeloid Leukemia
NCT06245746 ·Status: RECRUITING ·Phase: PHASE1
-
Chemotherapy Plus Peripheral Stem Cell Transplant in Treating Patients Who Have Multiple Myeloma or Primary Systemic Amyloidosis
NCT00007995 ·Status: COMPLETED ·Phase: PHASE2
-
Chemotherapy and Peripheral Stem Cell Transplantation in Treating Patients With Multiple Myeloma
NCT00014508 ·Status: COMPLETED ·Phase: PHASE2
-
Combination Chemotherapy Followed by Bone Marrow and/or Peripheral Stem Cell Transplantation in Treating Patients With Recurrent Medulloblastoma or CNS Germ Cell Tumors
NCT00002594 ·Status: COMPLETED ·Phase: PHASE2
-
High Dose Busulfan and Bortezomib in Treating Patients With High Risk Multiple Myeloma Undergoing Stem Cell Transplant
NCT01534143 ·Status: TERMINATED ·Phase: PHASE2
-
Health-Related Quality of Life (QOL), Physical and Respiratory Function in Patients With Myeloma Affecting the Spine
NCT01006070 ·Status: COMPLETED
-
Comparison Study of EAP and CG Regimens for Mobilizing Hematopoietic Stem Cells in Multiple Myeloma Patients
NCT06520176 ·Status: RECRUITING ·Phase: PHASE3
-
A Study to Explore Treatment Patterns, Treatment Outcomes, Healthcare Resource Utilization in Adult Participants With Myelofibrosis Through Chart Review
NCT05444972 ·Status: COMPLETED
-
High-Dose Melphalan, Total-Body Irradiation, and Peripheral Stem Cell Transplantation in Treating Patients With Multiple Myeloma in First Relapse
NCT00002630 ·Status: COMPLETED ·Phase: PHASE2
-
Total Skeletal Irradiation in Multiple Myeloma Before Second Autologous Hematopoietic Stem Cell Transplantation
NCT01182233 ·Status: TERMINATED ·Phase: PHASE1
-
Chemotherapy Plus Bone Marrow Transplantation in Treating Patients With Refractory Non-Hodgkin's Lymphoma, Hodgkin's Disease, or Multiple Myeloma
NCT00002552 ·Status: COMPLETED ·Phase: PHASE2
-
Stem Cell Transplantation for Metastatic Solid Tumors
NCT00001880 ·Status: TERMINATED ·Phase: PHASE2
-
Autologous Peripheral Blood Stem Cell Transplant Followed by Donor Bone Marrow Transplant in Treating Patients With High-Risk Hodgkin Lymphoma, Non-Hodgkin Lymphoma, Multiple Myeloma, or Chronic Lymphocytic Leukemia
NCT01008462 ·Status: COMPLETED ·Phase: PHASE2
-
Carfilzomib and Stem Cell Transplant for Plasma Cell Myeloma
NCT01658904 ·Status: TERMINATED ·Phase: PHASE1/PHASE2
-
Peripheral Stem Cell Transplantation in Treating Patients With Multiple Myeloma or Other B-cell Cancers
NCT00003163 ·Status: UNKNOWN ·Phase: PHASE2